nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR2A—cerebellar cortex—hypothyroidism	0.0311	0.106	CbGeAlD
Methysergide—Oliguria—Liotrix—hypothyroidism	0.0214	0.0361	CcSEcCtD
Methysergide—Tachycardia—Liothyronine—hypothyroidism	0.019	0.0321	CcSEcCtD
Methysergide—Blood urea increased—Liotrix—hypothyroidism	0.0186	0.0315	CcSEcCtD
Methysergide—HTR7—nerve—hypothyroidism	0.0183	0.0622	CbGeAlD
Methysergide—Lightheadedness—Liotrix—hypothyroidism	0.0177	0.0298	CcSEcCtD
Methysergide—HTR2A—urine—hypothyroidism	0.0165	0.0562	CbGeAlD
Methysergide—Body temperature increased—Liothyronine—hypothyroidism	0.0154	0.026	CcSEcCtD
Methysergide—Weight decreased—Dextrothyroxine—hypothyroidism	0.0152	0.0257	CcSEcCtD
Methysergide—Weight decreased—Levothyroxine—hypothyroidism	0.0152	0.0257	CcSEcCtD
Methysergide—HTR1E—female gonad—hypothyroidism	0.013	0.044	CbGeAlD
Methysergide—Flushing—Levothyroxine—hypothyroidism	0.0125	0.0211	CcSEcCtD
Methysergide—Flushing—Dextrothyroxine—hypothyroidism	0.0125	0.0211	CcSEcCtD
Methysergide—Alopecia—Dextrothyroxine—hypothyroidism	0.0119	0.0201	CcSEcCtD
Methysergide—Alopecia—Levothyroxine—hypothyroidism	0.0119	0.0201	CcSEcCtD
Methysergide—HTR2A—nerve—hypothyroidism	0.0114	0.0388	CbGeAlD
Methysergide—Weight decreased—Liotrix—hypothyroidism	0.0112	0.0189	CcSEcCtD
Methysergide—Convulsion—Dextrothyroxine—hypothyroidism	0.0102	0.0172	CcSEcCtD
Methysergide—Convulsion—Levothyroxine—hypothyroidism	0.0102	0.0172	CcSEcCtD
Methysergide—Arthralgia—Dextrothyroxine—hypothyroidism	0.00999	0.0169	CcSEcCtD
Methysergide—Arthralgia—Levothyroxine—hypothyroidism	0.00999	0.0169	CcSEcCtD
Methysergide—Tachycardia—Levothyroxine—hypothyroidism	0.00935	0.0158	CcSEcCtD
Methysergide—Tachycardia—Dextrothyroxine—hypothyroidism	0.00935	0.0158	CcSEcCtD
Methysergide—Flushing—Liotrix—hypothyroidism	0.0092	0.0155	CcSEcCtD
Methysergide—Alopecia—Liotrix—hypothyroidism	0.00876	0.0148	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00872	0.0147	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00872	0.0147	CcSEcCtD
Methysergide—Insomnia—Dextrothyroxine—hypothyroidism	0.00866	0.0146	CcSEcCtD
Methysergide—Insomnia—Levothyroxine—hypothyroidism	0.00866	0.0146	CcSEcCtD
Methysergide—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00854	0.0144	CcSEcCtD
Methysergide—Dyspnoea—Levothyroxine—hypothyroidism	0.00854	0.0144	CcSEcCtD
Methysergide—HTR1B—cardiovascular system—hypothyroidism	0.00831	0.0282	CbGeAlD
Methysergide—Fatigue—Dextrothyroxine—hypothyroidism	0.00826	0.0139	CcSEcCtD
Methysergide—Fatigue—Levothyroxine—hypothyroidism	0.00826	0.0139	CcSEcCtD
Methysergide—SIGMAR1—adrenal cortex—hypothyroidism	0.00822	0.0279	CbGeAlD
Methysergide—HTR2B—adrenal cortex—hypothyroidism	0.0082	0.0279	CbGeAlD
Methysergide—HTR1D—cardiovascular system—hypothyroidism	0.00805	0.0273	CbGeAlD
Methysergide—SIGMAR1—heart—hypothyroidism	0.00795	0.027	CbGeAlD
Methysergide—HTR2B—heart—hypothyroidism	0.00793	0.0269	CbGeAlD
Methysergide—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00789	0.0133	CcSEcCtD
Methysergide—Feeling abnormal—Levothyroxine—hypothyroidism	0.00789	0.0133	CcSEcCtD
Methysergide—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00783	0.0132	CcSEcCtD
Methysergide—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00783	0.0132	CcSEcCtD
Methysergide—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00757	0.0128	CcSEcCtD
Methysergide—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00757	0.0128	CcSEcCtD
Methysergide—Abdominal pain—Levothyroxine—hypothyroidism	0.00757	0.0128	CcSEcCtD
Methysergide—Body temperature increased—Levothyroxine—hypothyroidism	0.00757	0.0128	CcSEcCtD
Methysergide—HTR2B—cardiovascular system—hypothyroidism	0.00749	0.0254	CbGeAlD
Methysergide—Convulsion—Liotrix—hypothyroidism	0.00748	0.0126	CcSEcCtD
Methysergide—Chest pain—Liotrix—hypothyroidism	0.00735	0.0124	CcSEcCtD
Methysergide—Arthralgia—Liotrix—hypothyroidism	0.00735	0.0124	CcSEcCtD
Methysergide—Oedema—Liotrix—hypothyroidism	0.00704	0.0119	CcSEcCtD
Methysergide—Tachycardia—Liotrix—hypothyroidism	0.00687	0.0116	CcSEcCtD
Methysergide—Asthenia—Levothyroxine—hypothyroidism	0.00687	0.0116	CcSEcCtD
Methysergide—Asthenia—Dextrothyroxine—hypothyroidism	0.00687	0.0116	CcSEcCtD
Methysergide—HTR7—heart—hypothyroidism	0.00679	0.0231	CbGeAlD
Methysergide—HTR1A—cardiovascular system—hypothyroidism	0.00671	0.0228	CbGeAlD
Methysergide—SIGMAR1—pituitary gland—hypothyroidism	0.00664	0.0226	CbGeAlD
Methysergide—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00655	0.0111	CcSEcCtD
Methysergide—Diarrhoea—Levothyroxine—hypothyroidism	0.00655	0.0111	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00642	0.0108	CcSEcCtD
Methysergide—HTR7—cardiovascular system—hypothyroidism	0.00641	0.0218	CbGeAlD
Methysergide—Insomnia—Liotrix—hypothyroidism	0.00637	0.0108	CcSEcCtD
Methysergide—Paraesthesia—Liotrix—hypothyroidism	0.00633	0.0107	CcSEcCtD
Methysergide—Dyspnoea—Liotrix—hypothyroidism	0.00628	0.0106	CcSEcCtD
Methysergide—Vomiting—Levothyroxine—hypothyroidism	0.00609	0.0103	CcSEcCtD
Methysergide—Vomiting—Dextrothyroxine—hypothyroidism	0.00609	0.0103	CcSEcCtD
Methysergide—Fatigue—Liotrix—hypothyroidism	0.00607	0.0102	CcSEcCtD
Methysergide—Rash—Levothyroxine—hypothyroidism	0.00604	0.0102	CcSEcCtD
Methysergide—Rash—Dextrothyroxine—hypothyroidism	0.00604	0.0102	CcSEcCtD
Methysergide—Dermatitis—Levothyroxine—hypothyroidism	0.00603	0.0102	CcSEcCtD
Methysergide—Dermatitis—Dextrothyroxine—hypothyroidism	0.00603	0.0102	CcSEcCtD
Methysergide—Constipation—Liotrix—hypothyroidism	0.00602	0.0102	CcSEcCtD
Methysergide—SIGMAR1—adrenal gland—hypothyroidism	0.00594	0.0202	CbGeAlD
Methysergide—SIGMAR1—blood—hypothyroidism	0.00593	0.0202	CbGeAlD
Methysergide—HTR2B—adrenal gland—hypothyroidism	0.00592	0.0201	CbGeAlD
Methysergide—HTR2B—blood—hypothyroidism	0.00592	0.0201	CbGeAlD
Methysergide—HTR7—gonad—hypothyroidism	0.00582	0.0198	CbGeAlD
Methysergide—Feeling abnormal—Liotrix—hypothyroidism	0.0058	0.00979	CcSEcCtD
Methysergide—Gastrointestinal pain—Liotrix—hypothyroidism	0.00576	0.00972	CcSEcCtD
Methysergide—SIGMAR1—thyroid gland—hypothyroidism	0.00573	0.0195	CbGeAlD
Methysergide—HTR2B—thyroid gland—hypothyroidism	0.00572	0.0194	CbGeAlD
Methysergide—Nausea—Dextrothyroxine—hypothyroidism	0.00569	0.0096	CcSEcCtD
Methysergide—Nausea—Levothyroxine—hypothyroidism	0.00569	0.0096	CcSEcCtD
Methysergide—Body temperature increased—Liotrix—hypothyroidism	0.00557	0.0094	CcSEcCtD
Methysergide—Abdominal pain—Liotrix—hypothyroidism	0.00557	0.0094	CcSEcCtD
Methysergide—SIGMAR1—female gonad—hypothyroidism	0.00553	0.0188	CbGeAlD
Methysergide—HTR1A—adrenal gland—hypothyroidism	0.00531	0.018	CbGeAlD
Methysergide—HTR7—adrenal gland—hypothyroidism	0.00507	0.0172	CbGeAlD
Methysergide—HTR7—blood—hypothyroidism	0.00507	0.0172	CbGeAlD
Methysergide—Asthenia—Liotrix—hypothyroidism	0.00505	0.00853	CcSEcCtD
Methysergide—SIGMAR1—testis—hypothyroidism	0.00491	0.0167	CbGeAlD
Methysergide—Diarrhoea—Liotrix—hypothyroidism	0.00482	0.00813	CcSEcCtD
Methysergide—Dizziness—Liotrix—hypothyroidism	0.00466	0.00786	CcSEcCtD
Methysergide—SIGMAR1—liver—hypothyroidism	0.00464	0.0158	CbGeAlD
Methysergide—SIGMAR1—cerebellum—hypothyroidism	0.00453	0.0154	CbGeAlD
Methysergide—Vomiting—Liotrix—hypothyroidism	0.00448	0.00756	CcSEcCtD
Methysergide—Rash—Liotrix—hypothyroidism	0.00444	0.00749	CcSEcCtD
Methysergide—Dermatitis—Liotrix—hypothyroidism	0.00444	0.00749	CcSEcCtD
Methysergide—HTR2A—heart—hypothyroidism	0.00424	0.0144	CbGeAlD
Methysergide—HTR7—testis—hypothyroidism	0.00419	0.0142	CbGeAlD
Methysergide—Nausea—Liotrix—hypothyroidism	0.00418	0.00706	CcSEcCtD
Methysergide—HTR1A—cerebellum—hypothyroidism	0.00405	0.0138	CbGeAlD
Methysergide—HTR2A—cardiovascular system—hypothyroidism	0.004	0.0136	CbGeAlD
Methysergide—HTR7—liver—hypothyroidism	0.00397	0.0135	CbGeAlD
Methysergide—HTR7—cerebellum—hypothyroidism	0.00387	0.0132	CbGeAlD
Methysergide—HTR2A—gonad—hypothyroidism	0.00363	0.0123	CbGeAlD
Methysergide—HTR2A—pituitary gland—hypothyroidism	0.00354	0.012	CbGeAlD
Methysergide—HTR2A—adrenal gland—hypothyroidism	0.00316	0.0107	CbGeAlD
Methysergide—HTR2A—blood—hypothyroidism	0.00316	0.0107	CbGeAlD
Methysergide—HTR2A—testis—hypothyroidism	0.00262	0.00888	CbGeAlD
Methysergide—HTR2A—liver—hypothyroidism	0.00247	0.0084	CbGeAlD
Methysergide—HTR2A—cerebellum—hypothyroidism	0.00242	0.0082	CbGeAlD
Methysergide—HTR2A—G alpha (q) signalling events—AVP—hypothyroidism	0.000379	0.00336	CbGpPWpGaD
Methysergide—HTR1A—GPCR ligand binding—TSHB—hypothyroidism	0.000375	0.00333	CbGpPWpGaD
Methysergide—HTR1A—GPCR ligand binding—TSHR—hypothyroidism	0.000375	0.00333	CbGpPWpGaD
Methysergide—HTR2C—GPCR ligand binding—TSHR—hypothyroidism	0.000373	0.00331	CbGpPWpGaD
Methysergide—HTR2C—GPCR ligand binding—TSHB—hypothyroidism	0.000373	0.00331	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—TRH—hypothyroidism	0.000364	0.00322	CbGpPWpGaD
Methysergide—HTR2B—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000358	0.00317	CbGpPWpGaD
Methysergide—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000339	0.003	CbGpPWpGaD
Methysergide—HTR1D—G alpha (i) signalling events—POMC—hypothyroidism	0.000326	0.00288	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—TSHB—hypothyroidism	0.000324	0.00287	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—TSHR—hypothyroidism	0.000324	0.00287	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—TRH—hypothyroidism	0.000322	0.00285	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—TRH—hypothyroidism	0.000321	0.00284	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—TRH—hypothyroidism	0.000319	0.00283	CbGpPWpGaD
Methysergide—HTR1B—G alpha (i) signalling events—POMC—hypothyroidism	0.000319	0.00282	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—TRH—hypothyroidism	0.000312	0.00277	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—CLTC—hypothyroidism	0.00031	0.00274	CbGpPWpGaD
Methysergide—HTR1F—GPCR ligand binding—POMC—hypothyroidism	0.000308	0.00273	CbGpPWpGaD
Methysergide—HTR6—GPCR ligand binding—AVP—hypothyroidism	0.000299	0.00265	CbGpPWpGaD
Methysergide—HTR7—GPCR ligand binding—AVP—hypothyroidism	0.000299	0.00264	CbGpPWpGaD
Methysergide—HTR1D—GPCR ligand binding—AVP—hypothyroidism	0.000297	0.00263	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—TRH—hypothyroidism	0.000293	0.0026	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—CLTC—hypothyroidism	0.000292	0.00259	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—TRH—hypothyroidism	0.000292	0.00259	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—TRH—hypothyroidism	0.000292	0.00258	CbGpPWpGaD
Methysergide—HTR1E—GPCR ligand binding—POMC—hypothyroidism	0.000291	0.00258	CbGpPWpGaD
Methysergide—HTR1A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000291	0.00257	CbGpPWpGaD
Methysergide—HTR1B—GPCR ligand binding—AVP—hypothyroidism	0.00029	0.00257	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—TRH—hypothyroidism	0.00029	0.00257	CbGpPWpGaD
Methysergide—HTR2C—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000289	0.00256	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—TSHB—hypothyroidism	0.000287	0.00254	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—TSHR—hypothyroidism	0.000287	0.00254	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—TSHB—hypothyroidism	0.000286	0.00254	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—TSHR—hypothyroidism	0.000286	0.00254	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—TSHB—hypothyroidism	0.000284	0.00252	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—TSHR—hypothyroidism	0.000284	0.00252	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—TRH—hypothyroidism	0.000284	0.00251	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—TSHB—hypothyroidism	0.000278	0.00247	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—TSHR—hypothyroidism	0.000278	0.00247	CbGpPWpGaD
Methysergide—HTR2B—GPCR ligand binding—AVP—hypothyroidism	0.000273	0.00242	CbGpPWpGaD
Methysergide—HTR1F—GPCR downstream signaling—VAV3—hypothyroidism	0.000272	0.00241	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—TRH—hypothyroidism	0.000268	0.00237	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—TRH—hypothyroidism	0.000267	0.00236	CbGpPWpGaD
Methysergide—HTR1F—GPCR downstream signaling—AVP—hypothyroidism	0.000262	0.00232	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—TSHR—hypothyroidism	0.000262	0.00232	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—TSHB—hypothyroidism	0.000262	0.00232	CbGpPWpGaD
Methysergide—HTR6—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000261	0.00231	CbGpPWpGaD
Methysergide—HTR7—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000261	0.00231	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—TSHB—hypothyroidism	0.00026	0.00231	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—TSHR—hypothyroidism	0.00026	0.00231	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—TSHB—hypothyroidism	0.00026	0.0023	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—TSHR—hypothyroidism	0.00026	0.0023	CbGpPWpGaD
Methysergide—HTR1D—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000259	0.00229	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—TSHB—hypothyroidism	0.000258	0.00229	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—TSHR—hypothyroidism	0.000258	0.00229	CbGpPWpGaD
Methysergide—HTR1E—GPCR downstream signaling—VAV3—hypothyroidism	0.000257	0.00227	CbGpPWpGaD
Methysergide—HTR1B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000253	0.00224	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—TSHB—hypothyroidism	0.000253	0.00224	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—TSHR—hypothyroidism	0.000253	0.00224	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—TRH—hypothyroidism	0.000253	0.00224	CbGpPWpGaD
Methysergide—HTR2A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000251	0.00222	CbGpPWpGaD
Methysergide—HTR1E—GPCR downstream signaling—AVP—hypothyroidism	0.000247	0.00219	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—VAV3—hypothyroidism	0.000247	0.00219	CbGpPWpGaD
Methysergide—HTR1A—G alpha (i) signalling events—POMC—hypothyroidism	0.000243	0.00215	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—TSHR—hypothyroidism	0.000239	0.00211	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—TSHB—hypothyroidism	0.000239	0.00211	CbGpPWpGaD
Methysergide—HTR2B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000238	0.00211	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—AVP—hypothyroidism	0.000238	0.00211	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—TRH—hypothyroidism	0.000238	0.00211	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—TSHB—hypothyroidism	0.000238	0.0021	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—TSHR—hypothyroidism	0.000238	0.0021	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—TRH—hypothyroidism	0.000237	0.0021	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—VAV3—hypothyroidism	0.000233	0.00206	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—TSHB—hypothyroidism	0.000225	0.00199	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—TSHR—hypothyroidism	0.000225	0.00199	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—AVP—hypothyroidism	0.000225	0.00199	CbGpPWpGaD
Methysergide—HTR1A—GPCR ligand binding—AVP—hypothyroidism	0.000221	0.00196	CbGpPWpGaD
Methysergide—HTR2C—GPCR ligand binding—AVP—hypothyroidism	0.00022	0.00195	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—TRH—hypothyroidism	0.000216	0.00191	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—TRH—hypothyroidism	0.000215	0.0019	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—SH2B3—hypothyroidism	0.000213	0.00188	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—TSHB—hypothyroidism	0.000212	0.00188	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—TSHR—hypothyroidism	0.000212	0.00188	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—TSHB—hypothyroidism	0.000211	0.00187	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—TSHR—hypothyroidism	0.000211	0.00187	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—TRH—hypothyroidism	0.000206	0.00182	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—SH2B3—hypothyroidism	0.000201	0.00178	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CLTC—hypothyroidism	0.0002	0.00177	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CLTC—hypothyroidism	0.000199	0.00177	CbGpPWpGaD
Methysergide—HTR6—GPCR ligand binding—POMC—hypothyroidism	0.000199	0.00176	CbGpPWpGaD
Methysergide—HTR7—GPCR ligand binding—POMC—hypothyroidism	0.000198	0.00176	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CLTC—hypothyroidism	0.000198	0.00175	CbGpPWpGaD
Methysergide—HTR1D—GPCR ligand binding—POMC—hypothyroidism	0.000197	0.00175	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CLTC—hypothyroidism	0.000194	0.00172	CbGpPWpGaD
Methysergide—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000193	0.00171	CbGpPWpGaD
Methysergide—HTR1B—GPCR ligand binding—POMC—hypothyroidism	0.000193	0.00171	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—TSHB—hypothyroidism	0.000193	0.00171	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—TSHR—hypothyroidism	0.000193	0.00171	CbGpPWpGaD
Methysergide—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000192	0.0017	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—TSHB—hypothyroidism	0.000192	0.0017	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—TSHR—hypothyroidism	0.000192	0.0017	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—AVP—hypothyroidism	0.000191	0.00169	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—TRH—hypothyroidism	0.000187	0.00165	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—TSHB—hypothyroidism	0.000183	0.00162	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—TSHR—hypothyroidism	0.000183	0.00162	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CLTC—hypothyroidism	0.000182	0.00161	CbGpPWpGaD
Methysergide—HTR2B—GPCR ligand binding—POMC—hypothyroidism	0.000181	0.00161	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—VAV3—hypothyroidism	0.000175	0.00155	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—VAV3—hypothyroidism	0.000175	0.00155	CbGpPWpGaD
Methysergide—HTR1F—GPCR downstream signaling—POMC—hypothyroidism	0.000174	0.00154	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—VAV3—hypothyroidism	0.000174	0.00154	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TRH—hypothyroidism	0.000172	0.00153	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TRH—hypothyroidism	0.000172	0.00153	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TRH—hypothyroidism	0.000171	0.00152	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—VAV3—hypothyroidism	0.00017	0.00151	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—AVP—hypothyroidism	0.000169	0.0015	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—AVP—hypothyroidism	0.000169	0.00149	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—AVP—hypothyroidism	0.000168	0.00148	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TRH—hypothyroidism	0.000168	0.00148	CbGpPWpGaD
Methysergide—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000167	0.00148	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—TSHB—hypothyroidism	0.000166	0.00147	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—TSHR—hypothyroidism	0.000166	0.00147	CbGpPWpGaD
Methysergide—HTR1E—GPCR downstream signaling—POMC—hypothyroidism	0.000164	0.00146	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—AVP—hypothyroidism	0.000164	0.00145	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—VAV3—hypothyroidism	0.00016	0.00142	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—VAV3—hypothyroidism	0.000159	0.00141	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—VAV3—hypothyroidism	0.000159	0.00141	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—POMC—hypothyroidism	0.000158	0.0014	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—VAV3—hypothyroidism	0.000158	0.0014	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—PRL—hypothyroidism	0.000158	0.0014	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TRH—hypothyroidism	0.000157	0.00139	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—VAV3—hypothyroidism	0.000155	0.00137	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—AVP—hypothyroidism	0.000154	0.00137	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TSHB—hypothyroidism	0.000154	0.00136	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TSHR—hypothyroidism	0.000154	0.00136	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TSHR—hypothyroidism	0.000154	0.00136	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TSHB—hypothyroidism	0.000154	0.00136	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—AVP—hypothyroidism	0.000153	0.00136	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—AVP—hypothyroidism	0.000153	0.00136	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TSHB—hypothyroidism	0.000153	0.00135	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TSHR—hypothyroidism	0.000153	0.00135	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—AVP—hypothyroidism	0.000152	0.00135	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TSHB—hypothyroidism	0.000149	0.00132	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TSHR—hypothyroidism	0.000149	0.00132	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—POMC—hypothyroidism	0.000149	0.00132	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—AVP—hypothyroidism	0.000149	0.00132	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—PRL—hypothyroidism	0.000149	0.00132	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CLTC—hypothyroidism	0.000148	0.00131	CbGpPWpGaD
Methysergide—HTR1A—GPCR ligand binding—POMC—hypothyroidism	0.000147	0.0013	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CLTC—hypothyroidism	0.000147	0.0013	CbGpPWpGaD
Methysergide—HTR2C—GPCR ligand binding—POMC—hypothyroidism	0.000146	0.0013	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—VAV3—hypothyroidism	0.000146	0.00129	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—VAV3—hypothyroidism	0.000145	0.00129	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—AVP—hypothyroidism	0.000141	0.00125	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TSHB—hypothyroidism	0.00014	0.00124	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TSHR—hypothyroidism	0.00014	0.00124	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—AVP—hypothyroidism	0.00014	0.00124	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—VAV3—hypothyroidism	0.000138	0.00122	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—SH2B3—hypothyroidism	0.000137	0.00121	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—SH2B3—hypothyroidism	0.000137	0.00121	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—SH2B3—hypothyroidism	0.000136	0.0012	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—SH2B3—hypothyroidism	0.000133	0.00118	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—AVP—hypothyroidism	0.000133	0.00117	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—VAV3—hypothyroidism	0.00013	0.00115	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—VAV3—hypothyroidism	0.000129	0.00114	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TRH—hypothyroidism	0.000128	0.00113	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CLTC—hypothyroidism	0.000128	0.00113	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TRH—hypothyroidism	0.000127	0.00113	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—POMC—hypothyroidism	0.000127	0.00113	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—SH2B3—hypothyroidism	0.000125	0.00111	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—AVP—hypothyroidism	0.000125	0.00111	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—AVP—hypothyroidism	0.000124	0.0011	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—VAV3—hypothyroidism	0.000118	0.00104	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—VAV3—hypothyroidism	0.000117	0.00104	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TSHB—hypothyroidism	0.000114	0.00101	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TSHR—hypothyroidism	0.000114	0.00101	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—AVP—hypothyroidism	0.000114	0.00101	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TSHB—hypothyroidism	0.000113	0.001	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TSHR—hypothyroidism	0.000113	0.001	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—AVP—hypothyroidism	0.000113	0.001	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—POMC—hypothyroidism	0.000112	0.000994	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—POMC—hypothyroidism	0.000112	0.000993	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—VAV3—hypothyroidism	0.000112	0.000993	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—POMC—hypothyroidism	0.000111	0.000987	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TRH—hypothyroidism	0.00011	0.000977	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—POMC—hypothyroidism	0.000109	0.000966	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—AVP—hypothyroidism	0.000108	0.000957	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—POMC—hypothyroidism	0.000102	0.000908	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—POMC—hypothyroidism	0.000102	0.000903	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—POMC—hypothyroidism	0.000102	0.000902	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—VAV3—hypothyroidism	0.000102	0.000902	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—PRL—hypothyroidism	0.000102	0.0009	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—PRL—hypothyroidism	0.000102	0.000899	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—SH2B3—hypothyroidism	0.000101	0.000898	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—POMC—hypothyroidism	0.000101	0.000896	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—SH2B3—hypothyroidism	0.000101	0.000894	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—PRL—hypothyroidism	0.000101	0.000894	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—POMC—hypothyroidism	9.9e-05	0.000877	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PRL—hypothyroidism	9.88e-05	0.000875	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TSHB—hypothyroidism	9.83e-05	0.000871	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TSHR—hypothyroidism	9.83e-05	0.000871	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—AVP—hypothyroidism	9.81e-05	0.000869	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—VAV3—hypothyroidism	9.4e-05	0.000833	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—VAV3—hypothyroidism	9.39e-05	0.000832	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—POMC—hypothyroidism	9.34e-05	0.000828	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—VAV3—hypothyroidism	9.33e-05	0.000827	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—POMC—hypothyroidism	9.3e-05	0.000824	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PRL—hypothyroidism	9.28e-05	0.000822	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—VAV3—hypothyroidism	9.14e-05	0.000809	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—AVP—hypothyroidism	9.06e-05	0.000803	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—AVP—hypothyroidism	9.05e-05	0.000802	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—AVP—hypothyroidism	8.99e-05	0.000796	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IGF1—hypothyroidism	8.99e-05	0.000796	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—POMC—hypothyroidism	8.81e-05	0.000781	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—AVP—hypothyroidism	8.8e-05	0.00078	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SH2B3—hypothyroidism	8.76e-05	0.000776	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—VAV3—hypothyroidism	8.58e-05	0.00076	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IGF1—hypothyroidism	8.48e-05	0.000751	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—POMC—hypothyroidism	8.31e-05	0.000736	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—AVP—hypothyroidism	8.27e-05	0.000733	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—POMC—hypothyroidism	8.27e-05	0.000732	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—POMC—hypothyroidism	7.54e-05	0.000668	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PRL—hypothyroidism	7.52e-05	0.000667	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—POMC—hypothyroidism	7.51e-05	0.000665	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PRL—hypothyroidism	7.49e-05	0.000663	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—POMC—hypothyroidism	7.18e-05	0.000636	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—VAV3—hypothyroidism	6.96e-05	0.000617	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—VAV3—hypothyroidism	6.93e-05	0.000613	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—AVP—hypothyroidism	6.71e-05	0.000594	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—AVP—hypothyroidism	6.67e-05	0.000591	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—POMC—hypothyroidism	6.52e-05	0.000577	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PRL—hypothyroidism	6.5e-05	0.000576	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—POMC—hypothyroidism	6.02e-05	0.000533	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—POMC—hypothyroidism	6.01e-05	0.000533	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—VAV3—hypothyroidism	6.01e-05	0.000533	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—POMC—hypothyroidism	5.98e-05	0.000529	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—POMC—hypothyroidism	5.85e-05	0.000518	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—AVP—hypothyroidism	5.79e-05	0.000513	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IGF1—hypothyroidism	5.79e-05	0.000513	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IGF1—hypothyroidism	5.79e-05	0.000512	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IGF1—hypothyroidism	5.75e-05	0.000509	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IGF1—hypothyroidism	5.63e-05	0.000499	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—POMC—hypothyroidism	5.5e-05	0.000487	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IGF1—hypothyroidism	5.29e-05	0.000468	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—POMC—hypothyroidism	4.46e-05	0.000395	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—POMC—hypothyroidism	4.43e-05	0.000393	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IGF1—hypothyroidism	4.29e-05	0.00038	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IGF1—hypothyroidism	4.27e-05	0.000378	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—POMC—hypothyroidism	3.85e-05	0.000341	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IGF1—hypothyroidism	3.7e-05	0.000328	CbGpPWpGaD
